| Literature DB >> 26176558 |
Azza Abdel-Gawad Tantawy1, Amira Abdel-Monem Adly, Yasmine Ibrahim Elhenawy.
Abstract
Budd-Chiari syndrome (BCS) is a liver disorder characterized by hepatic venous outflow obstruction, mainly resulting from thrombosis of the terminal part of the hepatic veins or the inferior vena cava. It causes hepatic congestion, ascites, portal hypertension, and collateral circulation between the obstructed and contiguous patent venous territories. BCS is reported complicating myeloproliferative disorders, as well other prothrombotic events. Essential thrombocythemia is one of the most frequent myeloproliferative disorders that cause BCS, and in some cases, it may be the initial presentation. Many treatment options have been proposed for BCS, routine anticoagulation therapy being recommended as the first therapeutic approach.Entities:
Mesh:
Year: 2015 PMID: 26176558 DOI: 10.1097/MBC.0000000000000325
Source DB: PubMed Journal: Blood Coagul Fibrinolysis ISSN: 0957-5235 Impact factor: 1.276